As of 2025-11-18, the Relative Valuation of Allergy Therapeutics PLC (AGY.L) is (6.20) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 8.50 GBP, the upside of Allergy Therapeutics PLC based on Relative Valuation is -172.9%.
The range of the Relative Valuation is (6.12) - (5.85) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.2x - 10.2x | 9.2x |
| Forward P/E multiples | 10.7x - 13.1x | 12.4x |
| Fair Price | (6.12) - (5.85) | (6.20) |
| Upside | -171.9% - -168.8% | -172.9% |
| Date | P/E |
| 2025-11-14 | -14.78 |
| 2025-11-13 | -14.85 |
| 2025-11-12 | -15.04 |
| 2025-11-11 | -14.71 |
| 2025-11-10 | -15.60 |
| 2025-11-07 | -14.95 |
| 2025-11-06 | -14.85 |
| 2025-11-05 | -14.52 |
| 2025-11-04 | -14.79 |
| 2025-11-03 | -15.60 |
| 2025-10-31 | -15.21 |
| 2025-10-30 | -13.80 |
| 2025-10-29 | -14.78 |
| 2025-10-28 | -14.36 |
| 2025-10-27 | -14.38 |
| 2025-10-24 | -14.43 |
| 2025-10-23 | -14.32 |
| 2025-10-22 | -13.82 |
| 2025-10-21 | -13.84 |
| 2025-10-20 | -13.68 |
| 2025-10-17 | -13.64 |
| 2025-10-16 | -14.50 |
| 2025-10-15 | -13.99 |
| 2025-10-14 | -14.01 |
| 2025-10-13 | -14.03 |
| 2025-10-10 | -14.86 |
| 2025-10-09 | -14.41 |
| 2025-10-08 | -14.34 |
| 2025-10-07 | -14.01 |
| 2025-10-06 | -14.55 |
| 2025-10-03 | -14.95 |
| 2025-10-02 | -14.85 |
| 2025-10-01 | -14.78 |
| 2025-09-30 | -14.79 |
| 2025-09-29 | -14.81 |
| 2025-09-26 | -14.60 |
| 2025-09-25 | -14.50 |
| 2025-09-24 | -14.52 |
| 2025-09-23 | -14.53 |
| 2025-09-22 | -14.55 |
| 2025-09-19 | -14.60 |
| 2025-09-18 | -14.50 |
| 2025-09-17 | -14.34 |
| 2025-09-16 | -14.53 |
| 2025-09-15 | -14.55 |
| 2025-09-12 | -14.60 |
| 2025-09-11 | -14.50 |
| 2025-09-10 | -13.99 |
| 2025-09-09 | -14.18 |
| 2025-09-08 | -14.64 |